Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
10,400,675
-
Shares change
-
+164,270
-
Total reported value, excl. options
-
$168,280,869
-
Value change
-
+$261,666
-
Put/Call ratio
-
147%
-
Number of buys
-
43
-
Number of sells
-
31
-
Price
-
$16.18
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q3 2015
As of 30 Sep 2015 Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) had 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,400,675 shares of stock of the company.
Largest 10 holders included Birchview Capital, LP, CANNELL PETER B & CO INC, VANGUARD GROUP INC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., Miura Global Management, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, OBERMEYER WOOD INVESTMENT COUNSEL, LLLP, and Nuveen Asset Management, LLC.
This table shows 103 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.